Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFB9P3 is a pseudogene corresponding to the subunit B9 of NADH:ubiquinone oxidoreductase (mitochondrial complex I). Pseudogenes are genetic sequences that resemble known genes but have lost protein-coding ability or are otherwise non-functional due to mutations. Unlike the closely related and functional NDUFB9 gene, which codes for a structural subunit of mitochondrial complex I involved in oxidative phosphorylation, NDUFB9P3 does not produce a functional protein and is not implicated in mitochondrial activity, disease, or as a drug target[1]. NDUFB9P3 is not a receptor, enzyme, transporter, or valid drug target. It is a non-functional pseudogene, so it is not considered for therapeutic or biomarker use and does not have known implications in disease or pharmacology[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B9 pseudogene 3 (NDUFB9P3).